tradingkey.logo
tradingkey.logo
Search

Tandem Diabetes Care Inc

TNDM
Add to Watchlist
15.320USD
-0.430-2.73%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.05BMarket Cap
LossP/E TTM

Tandem Diabetes Care Inc

15.320
-0.430-2.73%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-2.73%

5 Days

+2.00%

1 Month

-19.87%

6 Months

-28.91%

Year to Date

-30.30%

1 Year

-11.14%

Key Figures
15.940Open
16.165High
1.63MVolume
LossP/E TTM
150.29P/E Dynamic
--Dividend TTM
2.38%Turnover Ratio
15.750Prev. Close
15.220Low
18.56MTurnover
LossP/E Static
7.93P/B
0.00%Div Yield TTM
-9.11%ROA
29.65052wk High
1.57Volume Ratio
-96.03MNet Profit
68.50MShares
-1.3745EPS TTM
1.59Beta
-65.73%ROE
9.98052wk Low
6.00%Amplitude
55.33%Gross Margin
1.05BMarket Cap
-3.13Reward/Risk
4.05%Risk Rate

Key Insights

Tandem Diabetes Care Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 71 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.88.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tandem Diabetes Care Inc's Score

Industry at a Glance

Industry Ranking
71 / 204
Overall Ranking
189 / 4564
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Tandem Diabetes Care Inc Highlights

StrengthsRisks
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 35.71% year-on-year.
Fairly Valued
The company’s latest PE is -11.46, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.22M shares, decreasing 10.14% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 900.81K shares of this stock.

Analyst Rating

Based on 23 analysts
Buy
Current Rating
28.875
Target Price
+82.41%
Upside Space

Tandem Diabetes Care Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Tandem Diabetes Care Inc Info

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Ticker SymbolTNDM
CompanyTandem Diabetes Care Inc
CEOSheridan (John F)
Websitehttps://www.tandemdiabetes.com/

FAQs

What is the current price of Tandem Diabetes Care Inc (TNDM)?

The current price of Tandem Diabetes Care Inc (TNDM) is 15.75.

What is the symbol of Tandem Diabetes Care Inc?

The ticker symbol of Tandem Diabetes Care Inc is TNDM.

What is the 52-week high of Tandem Diabetes Care Inc?

The 52-week high of Tandem Diabetes Care Inc is 29.65.

What is the 52-week low of Tandem Diabetes Care Inc?

The 52-week low of Tandem Diabetes Care Inc is 9.98.

What is the market capitalization of Tandem Diabetes Care Inc?

The market capitalization of Tandem Diabetes Care Inc is 1.08B.

Is Tandem Diabetes Care Inc (TNDM) currently rated as Buy, Hold, or Sell?

According to analysts, Tandem Diabetes Care Inc (TNDM) has an overall rating of Buy, with a price target of 28.88.

What is the Earnings Per Share (EPS TTM) of Tandem Diabetes Care Inc (TNDM)?

The Earnings Per Share (EPS TTM) of Tandem Diabetes Care Inc (TNDM) is -3.04.